Mousumi Patra
Researcher
Also affiliated: Winthrop Rockefeller Foundation (2026); University of Kalyani (2013–2022)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Mousumi Patra's research investigates the properties and applications of nanoparticles, particularly cerium oxide and calcium phosphate nanoparticles. Her work explores their potential roles as antioxidant or pro-oxidant agents, with applications in neural cell studies and zebrafish models. Patra also studies the mechanisms by which cellular factors and nanoparticles influence disease progression, including melanoma and lung cancer. Her research has involved investigating the role of SIRT2 in melanoma progression and its potential modulation by nicotinamide riboside to alleviate cisplatin-induced peripheral neuropathy. Patra has published 37 papers, with an h-index of 10 and 396 citations. She collaborates with researchers at the University of Arkansas for Medical Sciences, including Heba Allam and Ratan Sadhukhan.
Metrics
- h-index: 10
- Publications: 37
- Citations: 404
Selected Publications
-
SIRT2 mitigates radiation-induced oral mucositis by promoting homologous recombination-mediated DNA double-strand break repair in epithelial stem cells (2026)
-
GSK3B directs DNA repair choice and determines tumor response to PARP1 inhibition independent of BRCA1 (2025)
-
236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response (2025)
-
Sirt2 Mitigates Radiation-Induced Oral Mucositis by Promoting Homologous Recombination-Mediated DNA Double-Strand Break Repair in Epithelial Stem Cells (2025)
-
376 Inhibition of GSK3β-mediated 53BP1 T334 phosphorylation in T cells enhances infiltration and cytotoxicity against head and neck squamous cell carcinoma (2024)
-
Abstract PR011: Novel role of glycogen synthase kinase-3β in determining cancer cell response to PARPi through regulation of 53BP1 function (2024)
-
Novel Role of Glycogen Synthase Kinase-3β in Determining Cancer Cell Response to Genotoxic Stress through Regulation of 53BP1 Function (2023)
-
Objective quantification of responses to the clinical pull-test in people with Parkinson’s disease (2023)
-
Objective Quantification of Responses to the Clinical Pull-Test in People with Parkinson's Disease (2022)
-
Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation (2022)
-
Biosynthesized CdS Nanoparticle Induces ROS-dependent Apoptosis in Human LungCancer Cells (2021)
-
SIRT2 Promotes Murine Melanoma Progression Through Natural Killer Cell Inhibition (2021)
-
SIRT2 promotes murine melanoma progression through natural killer cell inhibition (2021)
-
SIRT2 Promotes Murine Melanoma Progression Through Natural Killer Cell Inhibition (2020)
-
Targeting Human Lung Cancer Cells by CdS Nanoparticle: a ROS Mediated Cell Death (2020)
Collaboration Network
Top Collaborators
- SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation
- Abstract PR011: Novel role of glycogen synthase kinase-3β in determining cancer cell response to PARPi through regulation of 53BP1 function
- 376 Inhibition of GSK3β-mediated 53BP1 T334 phosphorylation in T cells enhances infiltration and cytotoxicity against head and neck squamous cell carcinoma
- Sirt2 Mitigates Radiation-Induced Oral Mucositis by Promoting Homologous Recombination-Mediated DNA Double-Strand Break Repair in Epithelial Stem Cells
Showing 5 of 7 shared publications
- SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation
- SIRT2 Promotes Murine Melanoma Progression Through Natural Killer Cell Inhibition
- Novel Role of Glycogen Synthase Kinase-3β in Determining Cancer Cell Response to Genotoxic Stress through Regulation of 53BP1 Function
- Abstract PR011: Novel role of glycogen synthase kinase-3β in determining cancer cell response to PARPi through regulation of 53BP1 function
- Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation
- 376 Inhibition of GSK3β-mediated 53BP1 T334 phosphorylation in T cells enhances infiltration and cytotoxicity against head and neck squamous cell carcinoma
- Sirt2 Mitigates Radiation-Induced Oral Mucositis by Promoting Homologous Recombination-Mediated DNA Double-Strand Break Repair in Epithelial Stem Cells
- GSK3B directs DNA repair choice and determines tumor response to PARP1 inhibition independent of BRCA1
- SIRT2 mitigates radiation-induced oral mucositis by promoting homologous recombination-mediated DNA double-strand break repair in epithelial stem cells
- Novel Role of Glycogen Synthase Kinase-3β in Determining Cancer Cell Response to Genotoxic Stress through Regulation of 53BP1 Function
- Abstract PR011: Novel role of glycogen synthase kinase-3β in determining cancer cell response to PARPi through regulation of 53BP1 function
- 376 Inhibition of GSK3β-mediated 53BP1 T334 phosphorylation in T cells enhances infiltration and cytotoxicity against head and neck squamous cell carcinoma
- Sirt2 Mitigates Radiation-Induced Oral Mucositis by Promoting Homologous Recombination-Mediated DNA Double-Strand Break Repair in Epithelial Stem Cells
- GSK3B directs DNA repair choice and determines tumor response to PARP1 inhibition independent of BRCA1
- SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- SIRT2 Promotes Murine Melanoma Progression Through Natural Killer Cell Inhibition
- SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation
- SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- SIRT2 Promotes Murine Melanoma Progression Through Natural Killer Cell Inhibition
- Objective quantification of responses to the clinical pull-test in people with Parkinson’s disease
- Objective Quantification of Responses to the Clinical Pull-Test in People with Parkinson's Disease
- Objective quantification of responses to the clinical pull-test in people with Parkinson’s disease
- Objective Quantification of Responses to the Clinical Pull-Test in People with Parkinson's Disease
- Objective quantification of responses to the clinical pull-test in people with Parkinson’s disease
- Objective Quantification of Responses to the Clinical Pull-Test in People with Parkinson's Disease
- 376 Inhibition of GSK3β-mediated 53BP1 T334 phosphorylation in T cells enhances infiltration and cytotoxicity against head and neck squamous cell carcinoma
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
- 376 Inhibition of GSK3β-mediated 53BP1 T334 phosphorylation in T cells enhances infiltration and cytotoxicity against head and neck squamous cell carcinoma
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
- Sirt2 Mitigates Radiation-Induced Oral Mucositis by Promoting Homologous Recombination-Mediated DNA Double-Strand Break Repair in Epithelial Stem Cells
- SIRT2 mitigates radiation-induced oral mucositis by promoting homologous recombination-mediated DNA double-strand break repair in epithelial stem cells
- SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- SIRT2 promotes murine melanoma progression through natural killer cell inhibition
Similar Researchers
Based on overlapping research topics